ABOUT ELITE
PRODUCTS
PIPELINE
- Generic
- Branded
TECHNOLOGY
INVESTOR RELATIONS

HOME | CAREERS | CONTACT | NEWS |

Skip to content

About Elite
Products
Pipeline
- Generic
- Branded
Technology
Investor Relations

Press Releases

Select:

Jul 27, 2005 ELITE PHARMACEUTICALS TO PRESENT AT THE BANC OF AMERICA SECURITIES 2005 SPECIALTY PHARMACEUTICS CONFERENCE

Jun 28, 2005 Elite Pharmaceuticals Announces Agreement for the Development of a Controlled Release Product

Jun 22, 2005 Elite Pharmaceuticals and IntelliPharmaCeutics Announce Agreement for the Development of a Controlled Release Product

May 26, 2005 FDA Approves IND for Elite Pharmaceuticals Abuse-Resistant Oxycodone Product

Apr 26, 2005 Elite Pharmaceuticals Announces IND Filing for Abuse-Resistant Technology for Narcotic Analgesics

Apr 05, 2005 Elite Laboratories Announces Agreement For Development, Manufacture and Distribution of a Controlled Release Product

Mar 09, 2005 Elite Pharmaceuticals Announces Conversion of All Outstanding Series A Preferred Stock Into Common Stock

Jan 25, 2005 Elite Pharmaceuticals Announces Election of New Director to its Board and Date of Annual Stockholders Meeting

Nov 04, 2004 Elite Pharmaceuticals Completes Preferred Stock Private Placement and Raised a Total of $6.6 Million

Oct 28, 2004 Elite Pharmaceuticals Acknowledges Sale in Private Transaction by Former Controlling Shareholder

23 24 25 26 27 28 29 30

<< < > >>

Site Map | Privacy | Terms Of Use

Copyright © Elite Pharmaceuticals Inc. | All Rights Reserved.

ART™: Abuse-Resistant Technology for a safer healthier you.

Resize Viewer - Reduce

Resize Viewer - Expand